nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—Parkinsonism—Fluorouracil—colon cancer	0.0336	0.0336	CcSEcCtD
Tetrabenazine—Akathisia—Irinotecan—colon cancer	0.0288	0.0288	CcSEcCtD
Tetrabenazine—Balance disorder—Fluorouracil—colon cancer	0.0279	0.0279	CcSEcCtD
Tetrabenazine—Balance disorder—Capecitabine—colon cancer	0.0195	0.0195	CcSEcCtD
Tetrabenazine—Dysarthria—Irinotecan—colon cancer	0.0169	0.0169	CcSEcCtD
Tetrabenazine—Gait disturbance—Vincristine—colon cancer	0.0168	0.0168	CcSEcCtD
Tetrabenazine—Gait disturbance—Irinotecan—colon cancer	0.0163	0.0163	CcSEcCtD
Tetrabenazine—Dysarthria—Fluorouracil—colon cancer	0.0161	0.0161	CcSEcCtD
Tetrabenazine—Photophobia—Fluorouracil—colon cancer	0.0143	0.0143	CcSEcCtD
Tetrabenazine—Memory impairment—Capecitabine—colon cancer	0.0136	0.0136	CcSEcCtD
Tetrabenazine—Disorientation—Fluorouracil—colon cancer	0.0124	0.0124	CcSEcCtD
Tetrabenazine—Osteoarthritis—Irinotecan—colon cancer	0.0116	0.0116	CcSEcCtD
Tetrabenazine—Dysarthria—Capecitabine—colon cancer	0.0113	0.0113	CcSEcCtD
Tetrabenazine—Ataxia—Vincristine—colon cancer	0.0112	0.0112	CcSEcCtD
Tetrabenazine—Osteoarthritis—Fluorouracil—colon cancer	0.0111	0.0111	CcSEcCtD
Tetrabenazine—Gait disturbance—Capecitabine—colon cancer	0.0109	0.0109	CcSEcCtD
Tetrabenazine—Irritability—Fluorouracil—colon cancer	0.0106	0.0106	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Irinotecan—colon cancer	0.0106	0.0106	CcSEcCtD
Tetrabenazine—Ataxia—Fluorouracil—colon cancer	0.0104	0.0104	CcSEcCtD
Tetrabenazine—Ecchymosis—Capecitabine—colon cancer	0.00964	0.00964	CcSEcCtD
Tetrabenazine—Dysuria—Vincristine—colon cancer	0.0096	0.0096	CcSEcCtD
Tetrabenazine—Dysphagia—Fluorouracil—colon cancer	0.00958	0.00958	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Irinotecan—colon cancer	0.00929	0.00929	CcSEcCtD
Tetrabenazine—Depression—Vincristine—colon cancer	0.00913	0.00913	CcSEcCtD
Tetrabenazine—Sleep disorder—Capecitabine—colon cancer	0.00895	0.00895	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Fluorouracil—colon cancer	0.0089	0.0089	CcSEcCtD
Tetrabenazine—Sweating—Vincristine—colon cancer	0.00878	0.00878	CcSEcCtD
Tetrabenazine—Sweating—Irinotecan—colon cancer	0.00855	0.00855	CcSEcCtD
Tetrabenazine—Dysarthria—Methotrexate—colon cancer	0.0084	0.0084	CcSEcCtD
Tetrabenazine—Bradycardia—Irinotecan—colon cancer	0.00815	0.00815	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Vincristine—colon cancer	0.00812	0.00812	CcSEcCtD
Tetrabenazine—Urethral disorder—Vincristine—colon cancer	0.00806	0.00806	CcSEcCtD
Tetrabenazine—Osteoarthritis—Capecitabine—colon cancer	0.00774	0.00774	CcSEcCtD
Tetrabenazine—Cardiac disorder—Vincristine—colon cancer	0.00763	0.00763	CcSEcCtD
Tetrabenazine—Angiopathy—Vincristine—colon cancer	0.00746	0.00746	CcSEcCtD
Tetrabenazine—Cardiac disorder—Irinotecan—colon cancer	0.00743	0.00743	CcSEcCtD
Tetrabenazine—Irritability—Capecitabine—colon cancer	0.00739	0.00739	CcSEcCtD
Tetrabenazine—Ataxia—Capecitabine—colon cancer	0.00728	0.00728	CcSEcCtD
Tetrabenazine—Angiopathy—Irinotecan—colon cancer	0.00726	0.00726	CcSEcCtD
Tetrabenazine—Mental disorder—Vincristine—colon cancer	0.0072	0.0072	CcSEcCtD
Tetrabenazine—Ecchymosis—Methotrexate—colon cancer	0.00718	0.00718	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Capecitabine—colon cancer	0.00707	0.00707	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Capecitabine—colon cancer	0.00707	0.00707	CcSEcCtD
Tetrabenazine—Breast disorder—Capecitabine—colon cancer	0.007	0.007	CcSEcCtD
Tetrabenazine—Dysphagia—Capecitabine—colon cancer	0.00669	0.00669	CcSEcCtD
Tetrabenazine—Agitation—Vincristine—colon cancer	0.00657	0.00657	CcSEcCtD
Tetrabenazine—Bronchitis—Capecitabine—colon cancer	0.00644	0.00644	CcSEcCtD
Tetrabenazine—Leukopenia—Vincristine—colon cancer	0.0064	0.0064	CcSEcCtD
Tetrabenazine—Dysuria—Capecitabine—colon cancer	0.00626	0.00626	CcSEcCtD
Tetrabenazine—Leukopenia—Irinotecan—colon cancer	0.00624	0.00624	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Capecitabine—colon cancer	0.00622	0.00622	CcSEcCtD
Tetrabenazine—Leukopenia—Fluorouracil—colon cancer	0.00597	0.00597	CcSEcCtD
Tetrabenazine—Depression—Capecitabine—colon cancer	0.00595	0.00595	CcSEcCtD
Tetrabenazine—Osteoarthritis—Methotrexate—colon cancer	0.00576	0.00576	CcSEcCtD
Tetrabenazine—Confusional state—Irinotecan—colon cancer	0.00573	0.00573	CcSEcCtD
Tetrabenazine—Nervous system disorder—Vincristine—colon cancer	0.00573	0.00573	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Vincristine—colon cancer	0.00564	0.00564	CcSEcCtD
Tetrabenazine—Nervous system disorder—Irinotecan—colon cancer	0.00558	0.00558	CcSEcCtD
Tetrabenazine—Irritability—Methotrexate—colon cancer	0.0055	0.0055	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Irinotecan—colon cancer	0.0055	0.0055	CcSEcCtD
Tetrabenazine—Confusional state—Fluorouracil—colon cancer	0.00549	0.00549	CcSEcCtD
Tetrabenazine—Hypotension—Vincristine—colon cancer	0.00546	0.00546	CcSEcCtD
Tetrabenazine—Bradycardia—Capecitabine—colon cancer	0.00545	0.00545	CcSEcCtD
Tetrabenazine—Ataxia—Methotrexate—colon cancer	0.00542	0.00542	CcSEcCtD
Tetrabenazine—Nervous system disorder—Fluorouracil—colon cancer	0.00534	0.00534	CcSEcCtD
Tetrabenazine—Hypotension—Irinotecan—colon cancer	0.00531	0.00531	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Capecitabine—colon cancer	0.00529	0.00529	CcSEcCtD
Tetrabenazine—Insomnia—Vincristine—colon cancer	0.00528	0.00528	CcSEcCtD
Tetrabenazine—Urethral disorder—Capecitabine—colon cancer	0.00525	0.00525	CcSEcCtD
Tetrabenazine—Breast disorder—Methotrexate—colon cancer	0.00521	0.00521	CcSEcCtD
Tetrabenazine—Insomnia—Irinotecan—colon cancer	0.00514	0.00514	CcSEcCtD
Tetrabenazine—Hypotension—Fluorouracil—colon cancer	0.00509	0.00509	CcSEcCtD
Tetrabenazine—Decreased appetite—Vincristine—colon cancer	0.00508	0.00508	CcSEcCtD
Tetrabenazine—Dyspnoea—Irinotecan—colon cancer	0.00507	0.00507	CcSEcCtD
Tetrabenazine—Somnolence—Irinotecan—colon cancer	0.00506	0.00506	CcSEcCtD
Tetrabenazine—Fatigue—Vincristine—colon cancer	0.00503	0.00503	CcSEcCtD
Tetrabenazine—Eye disorder—Capecitabine—colon cancer	0.00501	0.00501	CcSEcCtD
Tetrabenazine—Constipation—Vincristine—colon cancer	0.00499	0.00499	CcSEcCtD
Tetrabenazine—Cardiac disorder—Capecitabine—colon cancer	0.00497	0.00497	CcSEcCtD
Tetrabenazine—Decreased appetite—Irinotecan—colon cancer	0.00494	0.00494	CcSEcCtD
Tetrabenazine—Insomnia—Fluorouracil—colon cancer	0.00493	0.00493	CcSEcCtD
Tetrabenazine—Fatigue—Irinotecan—colon cancer	0.0049	0.0049	CcSEcCtD
Tetrabenazine—Constipation—Irinotecan—colon cancer	0.00486	0.00486	CcSEcCtD
Tetrabenazine—Angiopathy—Capecitabine—colon cancer	0.00486	0.00486	CcSEcCtD
Tetrabenazine—Dyspnoea—Fluorouracil—colon cancer	0.00486	0.00486	CcSEcCtD
Tetrabenazine—Somnolence—Fluorouracil—colon cancer	0.00484	0.00484	CcSEcCtD
Tetrabenazine—Decreased appetite—Fluorouracil—colon cancer	0.00473	0.00473	CcSEcCtD
Tetrabenazine—Mental disorder—Capecitabine—colon cancer	0.00469	0.00469	CcSEcCtD
Tetrabenazine—Feeling abnormal—Irinotecan—colon cancer	0.00469	0.00469	CcSEcCtD
Tetrabenazine—Dysuria—Methotrexate—colon cancer	0.00466	0.00466	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Methotrexate—colon cancer	0.00463	0.00463	CcSEcCtD
Tetrabenazine—Body temperature increased—Vincristine—colon cancer	0.00462	0.00462	CcSEcCtD
Tetrabenazine—Body temperature increased—Irinotecan—colon cancer	0.0045	0.0045	CcSEcCtD
Tetrabenazine—Feeling abnormal—Fluorouracil—colon cancer	0.00449	0.00449	CcSEcCtD
Tetrabenazine—Drowsiness—Methotrexate—colon cancer	0.00444	0.00444	CcSEcCtD
Tetrabenazine—Depression—Methotrexate—colon cancer	0.00443	0.00443	CcSEcCtD
Tetrabenazine—Tremor—Capecitabine—colon cancer	0.00437	0.00437	CcSEcCtD
Tetrabenazine—Body temperature increased—Fluorouracil—colon cancer	0.00431	0.00431	CcSEcCtD
Tetrabenazine—Sweating—Methotrexate—colon cancer	0.00426	0.00426	CcSEcCtD
Tetrabenazine—Asthenia—Vincristine—colon cancer	0.00419	0.00419	CcSEcCtD
Tetrabenazine—Leukopenia—Capecitabine—colon cancer	0.00417	0.00417	CcSEcCtD
Tetrabenazine—Asthenia—Irinotecan—colon cancer	0.00408	0.00408	CcSEcCtD
Tetrabenazine—Diarrhoea—Vincristine—colon cancer	0.004	0.004	CcSEcCtD
Tetrabenazine—Anxiety—Capecitabine—colon cancer	0.00396	0.00396	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00394	0.00394	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Methotrexate—colon cancer	0.00394	0.00394	CcSEcCtD
Tetrabenazine—Urethral disorder—Methotrexate—colon cancer	0.00391	0.00391	CcSEcCtD
Tetrabenazine—Diarrhoea—Irinotecan—colon cancer	0.00389	0.00389	CcSEcCtD
Tetrabenazine—Dry mouth—Capecitabine—colon cancer	0.00388	0.00388	CcSEcCtD
Tetrabenazine—Dizziness—Vincristine—colon cancer	0.00386	0.00386	CcSEcCtD
Tetrabenazine—Confusional state—Capecitabine—colon cancer	0.00384	0.00384	CcSEcCtD
Tetrabenazine—Dizziness—Irinotecan—colon cancer	0.00376	0.00376	CcSEcCtD
Tetrabenazine—Nervous system disorder—Capecitabine—colon cancer	0.00373	0.00373	CcSEcCtD
Tetrabenazine—Eye disorder—Methotrexate—colon cancer	0.00373	0.00373	CcSEcCtD
Tetrabenazine—Diarrhoea—Fluorouracil—colon cancer	0.00373	0.00373	CcSEcCtD
Tetrabenazine—Vomiting—Vincristine—colon cancer	0.00371	0.00371	CcSEcCtD
Tetrabenazine—Cardiac disorder—Methotrexate—colon cancer	0.0037	0.0037	CcSEcCtD
Tetrabenazine—Skin disorder—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Capecitabine—colon cancer	0.00368	0.00368	CcSEcCtD
Tetrabenazine—Headache—Vincristine—colon cancer	0.00366	0.00366	CcSEcCtD
Tetrabenazine—Angiopathy—Methotrexate—colon cancer	0.00362	0.00362	CcSEcCtD
Tetrabenazine—Vomiting—Irinotecan—colon cancer	0.00362	0.00362	CcSEcCtD
Tetrabenazine—Dizziness—Fluorouracil—colon cancer	0.0036	0.0036	CcSEcCtD
Tetrabenazine—Headache—Irinotecan—colon cancer	0.00356	0.00356	CcSEcCtD
Tetrabenazine—Hypotension—Capecitabine—colon cancer	0.00356	0.00356	CcSEcCtD
Tetrabenazine—Mental disorder—Methotrexate—colon cancer	0.00349	0.00349	CcSEcCtD
Tetrabenazine—Nausea—Vincristine—colon cancer	0.00347	0.00347	CcSEcCtD
Tetrabenazine—Vomiting—Fluorouracil—colon cancer	0.00346	0.00346	CcSEcCtD
Tetrabenazine—Insomnia—Capecitabine—colon cancer	0.00344	0.00344	CcSEcCtD
Tetrabenazine—Headache—Fluorouracil—colon cancer	0.00341	0.00341	CcSEcCtD
Tetrabenazine—Dyspnoea—Capecitabine—colon cancer	0.00339	0.00339	CcSEcCtD
Tetrabenazine—Nausea—Irinotecan—colon cancer	0.00338	0.00338	CcSEcCtD
Tetrabenazine—Decreased appetite—Capecitabine—colon cancer	0.00331	0.00331	CcSEcCtD
Tetrabenazine—Fatigue—Capecitabine—colon cancer	0.00328	0.00328	CcSEcCtD
Tetrabenazine—Constipation—Capecitabine—colon cancer	0.00325	0.00325	CcSEcCtD
Tetrabenazine—Nausea—Fluorouracil—colon cancer	0.00323	0.00323	CcSEcCtD
Tetrabenazine—Feeling abnormal—Capecitabine—colon cancer	0.00314	0.00314	CcSEcCtD
Tetrabenazine—Leukopenia—Methotrexate—colon cancer	0.00311	0.00311	CcSEcCtD
Tetrabenazine—Body temperature increased—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00294	0.00294	CcSEcCtD
Tetrabenazine—Confusional state—Methotrexate—colon cancer	0.00286	0.00286	CcSEcCtD
Tetrabenazine—Nervous system disorder—Methotrexate—colon cancer	0.00278	0.00278	CcSEcCtD
Tetrabenazine—Skin disorder—Methotrexate—colon cancer	0.00275	0.00275	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Methotrexate—colon cancer	0.00274	0.00274	CcSEcCtD
Tetrabenazine—Asthenia—Capecitabine—colon cancer	0.00273	0.00273	CcSEcCtD
Tetrabenazine—Hypotension—Methotrexate—colon cancer	0.00265	0.00265	CcSEcCtD
Tetrabenazine—Diarrhoea—Capecitabine—colon cancer	0.0026	0.0026	CcSEcCtD
Tetrabenazine—Insomnia—Methotrexate—colon cancer	0.00256	0.00256	CcSEcCtD
Tetrabenazine—Dyspnoea—Methotrexate—colon cancer	0.00253	0.00253	CcSEcCtD
Tetrabenazine—Somnolence—Methotrexate—colon cancer	0.00252	0.00252	CcSEcCtD
Tetrabenazine—Dizziness—Capecitabine—colon cancer	0.00252	0.00252	CcSEcCtD
Tetrabenazine—Decreased appetite—Methotrexate—colon cancer	0.00246	0.00246	CcSEcCtD
Tetrabenazine—Fatigue—Methotrexate—colon cancer	0.00244	0.00244	CcSEcCtD
Tetrabenazine—Vomiting—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Tetrabenazine—Headache—Capecitabine—colon cancer	0.00238	0.00238	CcSEcCtD
Tetrabenazine—Feeling abnormal—Methotrexate—colon cancer	0.00233	0.00233	CcSEcCtD
Tetrabenazine—Nausea—Capecitabine—colon cancer	0.00226	0.00226	CcSEcCtD
Tetrabenazine—Body temperature increased—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Tetrabenazine—Asthenia—Methotrexate—colon cancer	0.00203	0.00203	CcSEcCtD
Tetrabenazine—Diarrhoea—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Tetrabenazine—Dizziness—Methotrexate—colon cancer	0.00187	0.00187	CcSEcCtD
Tetrabenazine—Vomiting—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Tetrabenazine—Headache—Methotrexate—colon cancer	0.00177	0.00177	CcSEcCtD
Tetrabenazine—Nausea—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
